↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$660KSold on the market
1Companies
Sep 3, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 202616:47 | Sep 2, 2026 | REGNREGENERON PHARMACEUTICALS, INC. | Director | S · Sell10b5-1 | $850.00 | −400 | 603 | -40% | −$340K | ||
| Sep 3, 202616:47 | Sep 2, 2026 | REGNREGENERON PHARMACEUTICALS, INC. | Director | M · Exercise10b5-1 | $719.37 | +400 | 1,003 | +66% | $288K | ||
| Aug 12, 202616:16 | Aug 10, 2026 | REGNREGENERON PHARMACEUTICALS, INC. | Director | S · Sell10b5-1 | $800.00 | −400 | 603 | -40% | −$320K | ||
| Aug 12, 202616:16 | Aug 10, 2026 | REGNREGENERON PHARMACEUTICALS, INC. | Director | M · Exercise10b5-1 | $719.37 | +400 | 1,003 | +66% | $288K |